Join to View Full Profile
3300 Gallows RdPathologyFalls Church, VA 22042
Phone+1 703-776-3441
Fax+1 703-776-3100
Dr. Goodman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Johns Hopkins UniversityResidency, Pathology-Anatomic and Clinical, 1975 - 1980
Vanderbilt University School of MedicineClass of 1975
Certifications & Licensure
MD State Medical License 1979 - 2026
VA State Medical License 2010 - 2026
DC State Medical License 2010 - 2013
FL State Medical License 2010 - 2012
PA State Medical License 2010 - 2010
American Board of Pathology Anatomic Pathology
Publications & Presentations
PubMed
- 1 citationsSevere acute liver disease in adults: Contemporary role of histopathology.Andrew D Clouston, Annette S H Gouw, Dina Tiniakos, Pierre Bedossa, Elizabeth M Brunt
Histopathology. 2024-10-01 - 1 citationsSteatohepatitic hepatocellular Carcinoma:A new approach to classifying morphological subtypes of hepatocellular carcinoma.Gwyneth S T Soon, Francesco Callea, Alastair D Burt, Sam Cook, Luigi Terracciano
Human Pathology. 2024-07-01 - 1 citationsSerologic extracellular matrix remodeling markers are related to fibrosis stage and prognosis in a phase 2b trial of simtuzumab in patients with primary sclerosing cho...Douglas Thorburn, Diana J Leeming, William T Barchuk, Ya Wang, Xiaomin Lu
Hepatology Communications. 2024-07-01
Journal Articles
- An Exploratory Study Examining How Nano-Liquid Chromatography–Mass Spectrometry and Phosphoproteomics Can Differentiate Patients with Advanced Fibrosis and Higher Perc...Zobair M Younossi, Zachary D Goodman, BioMed Central
Press Mentions
Major Histocompatibility Complex Class I‐Related Chain A Alleles and Histology of Nonalcoholic Fatty Liver DiseaseSeptember 30th, 2020
The Origins of the Modern‐Day Study of Drug Hepatotoxicity: Focus on Hyman J. ZimmermanMarch 2nd, 2020
New Long-Term Data Presented at AASLD Show Reduction in Liver Fibrosis and Cirrhosis in a Cohort of Patients with Lysosomal Acid Lipase Deficiency (LAL-D) Treated with Kanuma® (Sebelipase Alfa)November 11th, 2016
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
